Zydus launches in U.S. MSN Labs generic of Bayer’s PAH drug
Zydus Lifesciences has launched in the U.S. market Riociguat tablets, in multiple strengths, developed and manufactured by MSN Laboratories. The two companies are the first to launch the product, which is a generic version of Bayer’s Adempas. Approved by the U.S. Food and Drug Administration as a generic equivalent of Adempas tablets, in all five…
Read More “Zydus launches in U.S. MSN Labs generic of Bayer’s PAH drug” »